SEC Filing Details
Document Details
Form
Filing Date
Nov 22, 2022
Document Date
Nov 16, 2022
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
NeuroBo Pharmaceuticals, Inc.
Issuer
NEUROBO PHARMACEUTICALS, INC.
Filer
GOLDMAN SACHS GROUP INC